Home › Breast Carcinoma In Situ › NCT06153836

Neurotization of the Nipple Areolar Complex to Restore Sensation for Patients With Breast Cancer Undergoing Nipple Sparing Mastectomy and Reconstruction

Randomized Feasibility Study to Determine the Feasibility of Neurotization of the Nipple Areolar Complex at the Time of Nipple Sparing Mastectomy and Prosthetic Based Reconstruction

Who can join

Ages 18 and older · Women

Inclusion Criteria:

* Female patients age \>= 18
* Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2
* Planned nipple sparing mastectomy (NSM)
* Ideal NSM candidates would meet the following criteria:

  * Cup size A-C
  * BMI \<34
  * Ptosis grade \< 2
  * Clinical stage 0 - T2N0
  * Final planned implant volume \< 400cc
  * Inframammary or lateral mammary incision
  * Tumor \> 0.5cm from the nipple areolar complex (NAC)
  * No prior breast reduction, mastopexy, or periareolar incisions on side of planned NSM
  * No prior breast radiation on side of planned NSM
  * Tumor \<0.5cm from NAC (including suspicious calcifications or MRI enhancement)
  * No planned post mastectomy radiation (PMRT)
  * No nicotine use within 4 weeks of surgical date

Exclusion Criteria:

* Planned autologous reconstruction (immediate or delayed)
* Pregnancy

About the study

This phase II trial tests the willingness of patients undergoing nipple sparing mastectomy (NSM) to enroll in a randomized study of NSM with or without neurotization of the nipple areolar complex (NAC). This trial also compares patient reported outcomes, including quality of life and breast and NAC sexual functionality, for patients undergoing NSM with or without neurotization of the NAC. NSM is a standard practice option for patients undergoing preventative mastectomy, but many report dissatisfaction with decreased nipple sensation. Neurotization is a surgical technique using a nerve graft in an attempt to restore NAC sensation. Neurotization during NSM and reconstruction may restore NAC sensation and improve quality of life in breast cancer patients.

What is being tested

• Neurotization Procedure (procedure)
• Questionnaire Administration (other)
• Subcutaneous Mastectomy (procedure)

Sponsor: Mayo Clinic · Participants: 45 · Started: Dec 5, 2023

Contact the study team

• Clinical Trials Referral Office · Phone: 855-776-0015

Official record on ClinicalTrials.gov — NCT06153836

Locations in the U.S.

Conditions

• Breast Carcinoma In Situ

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.